ABSTRACT
Background Adverse early life exposures might negatively affect foetal and infant development, predisposing children to obesity. We aimed to systematically identify and evaluate risk factors for childhood obesity in preconception, pregnancy, and infancy, and assess their potential as targets for future prediction and prevention strategies.
Methods This systematic review (PROSPERO, CRD42022355152) included longitudinal studies from selected electronic databases published between inception and August 17th, 2022, identifying maternal, paternal, or infant risk factors from preconception until infancy for childhood obesity between 2 and 18 years. Screening and data extraction was performed through standardized extraction forms. We assessed risk factor quality on modifiability and predictive power using a piloted criteria template from ILSI-Europe-Marker-Validation-Initiative.
Findings We identified 172 observational and 5 intervention studies involving n=1.879.971 children from 37, predominantly high-income, countries. 59%, 25% and 16% of studies measured childhood obesity between 2- <6 years, 6-10 years, and >10 -18 years respectively. Average reported childhood obesity prevalence was 11·1%. Pregnancy and infancy risk factors were mostly studied. We identified 59 potential risk factors, 24 of which were consistently associated with childhood obesity risk. Higher maternal prepregnancy weight (n=28/31 positive associations from 31 studies, respectively), higher gestational weight gain (n=18/21), maternal smoking during pregnancy (n=23/29), higher birth weight (n=20/28), LGA (n=17/18), no breastfeeding (n=20/31), and higher infant weight gain (n=12/12) were the strongest risk factors, which may aid in prediction or be targets for prevention. Level of evidence was generally moderate due to unreliable exposure measurement, short follow-up/loss-to-follow up, and risk of confounding.
Interpretation We identified 7 early life risk factors, which were strongly associated with a higher risk of childhood obesity, and can contribute to future prediction and prevention strategies. These findings support implementation of prevention strategies targeting these early-life risk factors from a clinical and population perspective, where possible integrated with implementation studies.
Funding This work was conducted by an expert group of the European branch of the International Life Sciences Institute, ILSI Europe.
INTRODUCTION
Childhood obesity is a major public health challenge.1 Childhood obesity rates have rapidly increased over the past decades and continue to rise worldwide.2 Childhood obesity is related to increased risks of non-communicable diseases, including hypertension, diabetes, depression from childhood onwards and premature mortality in adulthood, leads to a reduced quality of life and large economic and societal burden .3–5
Accumulating evidence suggests that high susceptibility to obesity might already originate in early life.6,7 The Development Origins of Health and Disease (DOHaD) hypothesis states that in the early stages of human development, individuals are particularly vulnerable to an adverse environment.8,9 During preconception, egg cell maturation and sperm production occur. After conception, foetal life and early infancy are characterized by rapid cell division, organ development, and rapid growth. These stages define the blueprint of later health and disease; thus, adverse exposures during these critical developmental periods might predispose an individual to an increased risk of obesity in later life. As the prevalence of childhood obesity continues to rise, systematic identification of early-life risk factors for childhood obesity is urgently needed to enable development of improved prevention strategies with better early prediction of childhood obesity risk and potential novel modifiable targets for interventions at an individual and population level.
Therefore, we conducted a systematic review to first identify risk factors for childhood obesity in the preconception period, pregnancy, and infancy, thereby covering the critical first 1000 days of life. Second, we aimed to assess quality of potential crucial early-life risk factors for prediction of childhood obesity risk and as potential modifiable targets for future prevention strategies.
METHODS
Systematic review protocol development
This study was part of a large collaborative effort to perform a systematic review of risk factors in the first 1000 days of life for the development of various childhood cardiometabolic disorders. We developed a systematic review protocol to comprehensively include and evaluate individual research studies reporting on risk factors and noninvasive biomarkers during preconception, pregnancy and infancy for the development of various child and adolescent cardiometabolic disorders. For this study, we aimed to identify longitudinal observational or intervention studies that focused on association studies or prediction studies for early risk factors for childhood obesity between 2 and 18 years.
Risk factors and noninvasive biomarkers of interest, hereafter also referred to as “risk factors,” included sociodemographic factors, lifestyle factors, physical factors, environmental factors, pregnancy-related factors, and noninvasive biomarkers. We were interested in risk factors in mothers, fathers and offspring obtained during the crucial periods, preconception, pregnancy, and infancy until 2 years, together covering the first 1000 days of life. The outcome of interest was self-reported, physician or researcher-diagnosed obesity.
Data sources, search strategy, and screening criteria
We registered our search strategy and systematic review protocol to PROSPERO CRD42022355152. We developed search terms for Medline, EMBASE, Web of Science, SCOPUS and Cochrane CENTRAL (Text S1) for eligible citations published in English language through August 17th, 2022. We included prospective and retrospective longitudinal observational studies identifying factors of incident offspring outcomes of interest. We excluded cross-sectional studies and studies among diseased populations only. We also included interventions prospectively comparing treatment effects on the outcome. Exclusion criteria comprised studies with outcomes before the age of 2 years, studies reporting only intermediate phenotypes or continuous traits, or studies that only assessed endpoints outside of the cardiometabolic outcomes of interest. 2 independent reviewers screened at the title and abstract level. For accepted citations, 2 independent reviewers screened the full manuscripts. Conflicts at all screening stages were resolved by a third reviewer. Conflicts that were not resolved by the third reviewer were discussed in the full group. All screenings were conducted in the Covidence online systematic review tracking platform.
Data extraction and synthesis of results
We developed and piloted a data extraction template for eligible manuscripts, which included manuscript information, study level details and design, population enrolment and characteristics, exposure and outcome ascertainment and diagnosis criteria, and age at offspring outcome assessment. We classified exposures in 8 broad categories: (i) parental lifestyle factors, (ii) parental physical factors, (iii) environmental factors, (iv) pregnancy-related factors,(v) birth anthropometrics,(vi) feeding patterns, (vii) infant anthropometrics, and (viii) cord blood biomarkers.
Risk of bias assessment for quality and synthesis
We assessed quality of each study using the Joanna Briggs Institute (JBI) critical appraisal tools for cohort studies, case-control studies, and randomized controlled trials (RCTs).10 For cohort and case-control studies, we assessed quality based on 11 and 9 items, respectively that evaluated population recruitment, exposure and outcome ascertainment, confounding, statistical methodology and follow-up. For the RCTs, we evaluated 11 items that assessed selection and allocation, intervention, administration, outcome ascertainment, follow-up, and statistical analysis. JBI items were categorized as, ‘Yes,’ ‘No,’ ‘Unclear,’ or ‘Not applicable’ following established guidelines. Any uncertainty in assessment was further discussed by the full research team. Studies with overall scores of 50% or less on questions answered with ‘Yes’, 50% until 70% questions answered with ‘Yes’, and 70% or more questions answered with ‘Yes’, were considered low, moderate and high quality, respectively.
Quality assessment of risk factors for prediction and prevention
We took forward those risk factors we considered consistently associated with childhood obesity for quality assessment. We defined a consistently associated risk factor as a risk factor for which over 50% of studies reported an association in the same direction, in at least 2 studies of moderate or high quality. We developed and piloted a criteria template for risk factor quality assessment based on the ILSI Europe Marker Validation Initiative (Table S1).11 Early life risk factors were scored on their methodological aspects, reflection of the study objective, prediction, and modifiability. Risk factors were scored by 3 independent reviewers at 4 different levels based on the criteria: very strong, strong, medium, and low. Conflicts were discussed in the full group until consensus was reached. Risk factors, which scored strong or very strong on prediction (65% of studies reported an association in the same direction in at least five moderate or high quality studies; >80% of studies reported an association in the same direction in at least five moderate or high quality studies, respectively) and strong or very strong on modifiability were considered to be most the most useful risk factors for prediction and prevention strategies. Modifiability was based on two components: theoretically modifiable and findings from intervention studies. If a risk factor scored strong or very strong on theoretically modifiable (risk factor is modifiable on individual level and implementation of modifications in daily life is complicated or easy, respectively) and low on intervention studies (No intervention studies have been conducted, or no potential effect of modification has been found), it was considered strong. Very strong on modifiability was considered if a risk factor scored strong or very strong on theoretically modifiable scored and at least medium on intervention studies (There is some evidence of potential effect of intervention on the outcome, but literature is controversial, or higher respectively).
RESULTS
Study selection and participant characteristics
Figure 1 shows 35584 publications were identified for screening through searches of selected electronic databases. After removing 17974 duplicates, 17610 publications were subjected to title and abstract screening by 2 independent reviewers. 16059 publications were found to be irrelevant, and 1551 publications underwent full text screening. 177 studies met the inclusion criteria and were included in this review.
165 were observational studies, 7 were case-control studies and 5 were intervention studies (Table 1). Studies were performed between 1970 and 2022. Sample sizes varied from 50 to 155411 participants, leading to 1879971 children included in the final study sample. 59% of studies measured childhood obesity between 2 to 6 years, 25% between 6 to 10 years, and 16% between 10 and 18 years. Figure 2A shows that studies included data from 37 different countries, predominantly high-income countries. The average reported prevalence of obesity was 11·1%, which ranged from 0·9% in Peru to 19·6% in Finland (Figure 2B).
Risk factors for childhood obesity in preconception
We identified 34 observational studies and no RCTs that assessed 6 risk factors associated with childhood obesity in the preconception period ((Figure 3A1&3B1, Table S2). Maternal physical factors were most frequently studied. 19 observational studies reported that higher maternal preconception weight was associated with an increased risk of childhood obesity, whereas 3 observational studies11–13 found no association. Samples sizes varied from 205 to 5156. All identified studies showed that maternal prepregnancy overweight or obesity was associated with a higher risk of childhood obesity. Only 1 study14 reported paternal overweight or obesity as risk factor for childhood obesity. 4 observational studies15–18 focused on the associations of maternal lifestyle factors during preconception with childhood obesity risk. 2 observational studies15,16 showed that maternal smoking in the preconception period was associated with an increased risk of childhood obesity, whereas no associations with the risk of childhood obesity were reported for maternal preconception diet15,17 or physical activity15,18.
Risk factors for childhood obesity during pregnancy
We identified 135 observational studies and 2 RCTs that assessed 46 different risk factors during pregnancy (Figure 3A2&3B2, Table S2). Most frequently studied characteristics were birth characteristics and parental lifestyle factors. Most risk factors were assessed in mother and child. Only 4 studies reported paternal data13,19–21.
The most commonly reported risk factor was birthweight, assessed continuously, with 2012,14,19,22–38 of 28 observational studies reporting that a higher birthweight was associated with a higher risk for childhood obesity, and 1720,39–54 of 18 observational studies identifying large for gestational age (LGA) as a risk factor for childhood obesity. For small for gestational age (SGA) at birth, findings were less consistent. 4 observational studies31,55–57 identified SGA as a risk for childhood obesity, however, eight observational studies11,39,49,52,53,58–60 reported that SGA was associated with a lower risk of childhood obesity. Most observational studies assessing gestational age12,29,61–63 at birth and or pre- and late-term birth26,64–66 reported no evidence for higher risk for childhood obesity. 29 observational studies focused on parental physical factors. The majority investigated the association of (excessive) maternal gestational weight gain with childhood obesity, 1426,37,51,60,61,66–74 of 16 observational studies reported an increased risk of childhood obesity associated with higher gestational weight gain.
Most studies on pregnancy complications have focused on mode of delivery and gestational diabetes. Within 1451,52,61,75–85 out of 22 studied populations, caesarean section (CS) was identified as a risk factor for increased childhood obesity. 7 observational studies11,38,66,77,86–88 and 1 RCT89 reported no association between CS and childhood obesity. Gestational diabetes was identified as risk factor for childhood obesity in 12 out of 21 observational studies49,61,78,90–98 . 2511,14,16,26,29,32,36,51,52,66,78,99–112 out of 31 observational studies showed that maternal smoking during pregnancy was associated with a higher risk for childhood obesity. 10 observational studies23,107,108,111,113–118 and 1 RCT119 on maternal diet during pregnancy reached no consensus on the association with childhood obesity, partly because of the diversity of diets investigated. No consistent evidence was found for maternal age, socioeconomic status, ethnicity, parity, employment, relationship status, maternal or paternal education, and paternal age as risk factors for childhood obesity. Lower household income13,52,120 was reported within 3 out of 4 studies as risk factor for obesity in childhood.
Only 3 publications114,121,122 explored different cord blood biomarkers in relation to childhood obesity. Risk factors were fatty acids114, leptin and adiponectin121 and differences in metabolomics122, and no consensus on associations with childhood obesity was reached.
Risk factors for childhood obesity during infancy
We identified 76 observational studies and 3 RCTs that assessed 7 different exposures during infancy (Figure 3A3&3B3). The most frequently studied characteristic was feeding pattern. All risk factors were assessed in the child. 2011,32,36,39,54,60,66,70,78,123–133 out of 30 observational studies on breastfeeding reported that a breastfed child had lower risks of obesity as compared to a non- breastfed child. Furthermore, 15 observational studies13,26,63,99,102,124,131,134–141 reported that longer breastfeeding duration was associated with less childhood obesity, however 2 RCTs142,143 and 13 observational studies12,23,33,62,104,129,132,144–149 did not report an effect of the duration of breastfeeding on childhood obesity. All 16 observational studies12,29,45,51,52,58–60,65,150–156 focusing on body mass index (BMI) or weight gain during infancy reported that higher BMI or weight gain was associated with a higher risk of childhood obesity.
Risk of bias assessment for quality and synthesis
Level of evidence was generally scored as moderate quality, mainly due suboptimal assessment of the exposure or outcome, inadequate blinding of participants and researchers in RCTs, high risk of residual confounding, short duration of follow-up, and high loss-to-follow up (Figure 4). 6% of included studies was of low quality, consisting of 1 RCT and 10 cohort studies. Supplemental figures 1A-C--3A-D show the detailed bias assessments for all included studies based on the JBI checklist.
Quality assessment of risk factors for prediction and prevention
In total, we identified 24 risk factors consistently associated with childhood obesity, which included: maternal prepregnancy/pregnancy weight/overweight/obesity (hereafter maternal prepregnancy and pregnancy weight status), prepregnancy/pregnancy smoking, caesarean section, gestational diabetes, antibiotic use, education, household income, sleep duration, gestational weight gain/excessive gestational weight gain (hereafter maternal gestational weight gain), environmental chemical exposure, paternal prepregnancy/pregnancy weight/overweight/obesity, continuous foetal growth, birthweight/high birthweight/LGA, breastfeeding/duration of breastfeeding, milk formula content, infant BMI/weight/and BMI/weight gain.
We evaluated these risk factors for their potential for prediction and prevention strategies (Figure S4). In preconception, only maternal weight status scored very strong on its predictability and strong on modifiability. In pregnancy, maternal smoking, weight status, gestational weight gain, and birthweight/LGA scored strong or higher on prediction and modifiability. In infancy, only breastfeeding and infant BMI/weight change scored strong or very strong for their potential as predictor and to be modifiable on individual level.
DISCUSSION
In this systematic review, we identified 172 observational and 5 intervention studies from 37 countries that studied risk factors for childhood obesity in the first 1000 days of life. Most studies were performed in high-income countries and focused on identification of risk factors in pregnancy. 24 risk factors were consistently associated with the risk of childhood obesity. Higher maternal prepregnancy weight, higher gestational weight gain, maternal smoking during pregnancy, higher birthweight, LGA, no breastfeeding, and higher infant weight gain were the strongest risk factors for childhood obesity and need to be considered in future prediction or prevention strategies. Overall level of evidence was generally moderate due to unreliable measurements of exposures, short follow-up duration and loss to follow-up, and risk of residual confounding.
This current review provides the most comprehensive, systematic, up-to-date information on family-based risk factors for childhood obesity from preconception until infancy, thereby covering the full first 1000 days of life.157 Due to the large heterogeneity between studies, we could not perform meta-analyses. Despite increasing awareness on the importance of the preconception period for offspring health, only a remarkable low number of studies focused on risk factors in this potential critical period. Maternal prepregnancy weight status was consistently associated with childhood obesity, but no consistent effects were found for other maternal lifestyle factors. The transgenerational effects of increased maternal prepregnancy weight on childhood obesity risk poses a major public health concern, as obesity often progresses into adulthood, subsequently causing increased risks for the next generation.2 Only 1 publication focused on paternal factors and reported that higher paternal prepregnancy BMI was associated with a higher childhood obesity risk . Adverse paternal sociodemographic and lifestyle factors have already been shown to be associated with adverse pregnancy outcomes.158 Animal studies have shown that these paternal factors also increase the risk of childhood obesity, with the strongest effects for paternal obesity, but also for paternal hyperglycaemia and paternal smoking.159
As expected, pregnancy was the most studied period for risk factors for childhood obesity. Most studies focused on maternal and foetal risk factors. Suboptimal maternal gestational weight status and gestational weight gain were consistently associated with the risk of childhood obesity. Gestational diabetes and gestational hypertensive disorders tended to be associated with a higher risk of childhood obesity, but this was not consistent in moderate to high quality studies. Indeed, a previous individual-participant-data meta-analysis among 160757 mother-offspring pairs from European and North-American birth cohorts, also reported that no effect of gestational diabetes or gestational hypertensive disorders was present on childhood obesity after adjustment for maternal prepregnancy BMI.160 A higher birthweight and LGA were strong risk factors for childhood obesity, whereas associations for SGA and preterm birth were inconclusive. Children born SGA may be constitutionally small or have suffered from intra-uterine foetal growth restriction. Differences in this pathophysiology may partly explain these inconsistent findings.161 A lower household income and lower maternal and paternal education level tended to be associated with a higher risk of childhood obesity, but only inconsistent in less than 5 studies of at least moderate quality. As these findings are less consistent, generalizability is more difficult. Possibly, these effects are more country-specific and influenced by community and social support practices per region. Several moderate and high quality studies reported an association between CS and a higher risk for childhood obesity. All were observational studies, and the only included RCT did not support that association, suggesting that residual confounding may play a role in these observed associations. Maternal antibiotics during pregnancy was associated with childhood obesity in 50% of studies, but the number of studies was low, and associations were only found in females162, or not in all investigated age groups163,164, so no generalized conclusion can be drawn. No consistent associations were present for maternal or paternal age, ethnicity or parity.
In infancy, infant weight gain and feeding patterns were mostly studied with regards to the development of childhood obesity. Strongest associations were present for higher infant weight or BMI gain with higher risks of obesity. The infant period reflects the greatest proportional weight gain in postnatal life and might be a critical period for development of energy balance mechanisms. Early exposure to excess and dysfunctional fat mass might trigger the development of metabolic changes in childhood.165 Additionally, early weight gain may reflect the beginning influence of a genetic predisposition to overweight.166 Being breast-fed and a longer duration of breastfeeding were associated with lower risks of childhood obesity within the majority of reported observational studies. The only two intervention studies142,143, did not identify a significant association between the duration of breastfeeding and childhood obesity. Causality between the protective role of breastfeeding on development of childhood obesity can therefore not be properly determined based on these findings. It is remarkable that we identified no studies on the role of different components of breastmilk and only 3 studies on differences in infant formula composition.125,137,167
Our findings are important from an etiological perspective and provide novels insights to improve prediction and prevention strategies from the start of life onwards. Improved risk selection from early-life onwards is crucial to enable more targeted delivery of prevention strategies. Prevention strategies focused on improving these identified early-life risk factors from a clinical and population perspective is needed targeting those families at higher risk of offspring obesity, preferable integrated with implementation studies to evaluate risk selection, intervention effects and optimize delivery methods. The first 1000 days of life offer an are unique opportunity for prevention, because of parental motivation and contact with the health care system.168,169
Our systematic review also identified major areas for further research. First, studies were conducted in mainly high-income, countries. To increase global generalizability, more studies should be performed in low- and middle income countries, in which the rise of childhood obesity is most rapidly increasing and prevalence of identified risk factors may vary as compared to higher income countries.2 Second, we only identified few studies in preconception and infancy, whereas both periods are increasingly recognized as critical periods for childhood obesity development.170 Additionally, limited number of studies focused on paternal factors, environmental factors, metabolomics, and genetic factors. Evidence is increasing on the role of environmental exposures in human health, and investigation of their role in development of childhood obesity is warranted, as they are ubiquitous and represent an opportunity for governmental and political intervention. The field of omics is expanding rapidly, and further insight in the value of metabolomics and genomics for prediction of childhood obesity is of interest. Third, our findings are mainly based on observational studies, and causality cannot be established from observational evidence.171 Quality assessment showed many studies were at risk of residual confounding. We identified only 5 intervention studies, which included childhood obesity as outcome. 1 RCT investigated the role of maternal low glycaemic index diet during pregnancy119, 2 RCT’s investigated the duration of breastfeeding142,143 and 1 RCT investigated the difference between infant formula with high protein and low protein167. Especially in pregnancy, maternal lifestyle interventions have been conducted in RCTs, but these studies often did not include childhood obesity as a primary or secondary outcome and suffered from high attrition. Our systematic review underlines the urgent importance of well-designed intervention studies targeting parental lifestyle from preconception onwards with longer follow-up of the offspring and inclusion of clinical cardiometabolic outcomes.
CONCLUSION
We showed that 24 risk factors in early life are consistently associated with a higher risk of childhood obesity. Higher maternal prepregnancy weight and gestational weight gain, maternal smoking during pregnancy, higher birthweight and large-size-for-gestational-age-at-birth, no breastfeeding, and higher infant weight gain are most strongly related to childhood obesity risk. These findings are relevant for early life risk prediction and insight into the strongest potential modifiable factors from a clinical, governmental, and industrial perspective.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Funding
This work was conducted by an expert group of the European branch of the International Life Sciences Institute, ILSI Europe. This publication was coordinated by the Early Nutrition and Long- term Health Task Force. Industry members of this task force are listed on the ILSI Europe website at https://ilsi.eu/scientific-activities/nutrition/early-nutrition-and-long-term-health/. Experts are not paid for the time spent on this work. However, the nonindustry members within the expert group were offered support for travel on costs from the Early Nutrition and Long-term Health Task Force to attend 1 live meeting to discuss the manuscript. The expert group carried out the work, that is collecting/analysing data/information and writing the scientific paper separate to other activities of the task force. The research reported is the result of a scientific evaluation in line with ILSI Europe’s framework to provide a precompetitive setting for public-private partnership. ILSI Europe facilitated scientific meetings and coordinated the overall project management and administrative tasks relating to the completion of this work. For further information about ILSI Europe, please email info{at}ilsieurope.be or call +3227710014. The opinions expressed herein and the conclusions of this publication are those of the authors and do not necessarily represent the views of ILSI Europe nor those of its member companies or any regulatory authority.
AUTHOR CONTRIBUTIONS
SMB: Drafted the initial version of the manuscript, completed the review, extraction, and quality assessment of papers.
ASJK: Drafted the initial version of the manuscript, completed the review, extraction, and quality assessment of papers.
FJRO: Completed the review, extraction, and quality assessment of papers, provided critical intellectual feedback.
MBH: provided extraction of the data and provided critical intellectual feedback and completed quality assessment of papers.
EFV: provided extraction of the data and provided critical intellectual feedback. MAB: provided extraction of the data and provided critical intellectual feedback. MCC: provided extraction of the data and provided critical intellectual feedback.
JvD: Set up the initial aim of the study and study protocol, provided extraction of the data and provided critical intellectual feedback.
PI: provided extraction of the data and provided critical intellectual feedback. KK: provided extraction of the data and provided critical intellectual feedback.
CAvLB: provided extraction of the data and provided critical intellectual feedback.
AG: Completed the review, extraction, and quality assessment of papers and provided critical intellectual feedback.
RG: Set up the initial aim of the study and study protocol, completed the review, extraction, and quality assessment of papers, drafted the initial version of the manuscript.
All authors approved the final version for publication.
COMPETING INTERESTS STATEMENT
All authors declare no competing interests.
ACKNOWLEDGEMENTS
RG received funding from the Netherlands Organization for Health Research and Development (ZonMW, grant number 543003109) and funding from the European Union’s Horizon 2020 research and innovation program under the ERA-NET Cofund action (No. 727565), European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL), EndObesity, ZonMW Netherlands (No. 529051026). SMB was supported by the KNAW Ter Meulen Grant/KNAW Medical Science Fund, Royal Netherlands Academy of Arts & Sciences, and by ILSI Europe. ASJK was supported by ISLI Europe. MCC acknowledges the support by the Spanish Ministry of Science and Innovation (MCIN) research grant (ref. PID2022-139475OB-I00) and the award from MCIN/AEI to the Institute of Agrochemistry and Food Technology (IATA- CSIC) as Centre of Excellence Severo Ochoa (CEX2021-001189-S MCIN/AEI /10.13039/ 501100011033). EFV was supported by a Predoctoral grant awarded by the Spanish Ministry of Science and Innovation and the European Social Fund Plus (ESF+) for the training of doctors within the framework of the State Plan for Scientific, Technical and Innovation Research 2021 - 2023. (ref. CEX2021-001189-S-20-1). FJRO was supported by the Spanish Goverment (Juan de la Cierva programm, Ministry of Science and Innovation). This Project was executed in collaboration with Early Nutrition and Long-term Health Task Force of the European Branch of the International Life Sciences Institute (ILSI Europe). Industry members of this task force are listed on the website www.ilsi.eu. For more information, please contact ILSI Europe by email info{at}ilsieurope.be or call +32 2 771.00.14. The opinions expressed herein, and the conclusion of the project are those of the authors and do not necessarily represent the view of ILSI Europe nor those of its member companies.
Footnotes
Abbreviations
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- 23.↵
- 24.
- 25.
- 26.↵
- 27.
- 28.
- 29.↵
- 30.
- 31.↵
- 32.↵
- 33.↵
- 34.
- 35.
- 36.↵
- 37.↵
- 38.↵
- 39.↵
- 40.
- 41.
- 42.
- 43.
- 44.
- 45.↵
- 46.
- 47.
- 48.
- 49.↵
- 50.
- 51.↵
- 52.↵
- 53.↵
- 54.↵
- 55.↵
- 56.
- 57.↵
- 58.↵
- 59.
- 60.↵
- 61.↵
- 62.↵
- 63.↵
- 64.↵
- 65.↵
- 66.↵
- 67.
- 68.
- 69.
- 70.↵
- 71.
- 72.
- 73.
- 74.↵
- 75.↵
- 76.
- 77.↵
- 78.↵
- 79.
- 80.
- 81.
- 82.
- 83.
- 84.
- 85.↵
- 86.↵
- 87.
- 88.↵
- 89.↵
- 90.↵
- 91.
- 92.
- 93.
- 94.
- 95.
- 96.
- 97.
- 98.↵
- 99.↵
- 100.
- 101.
- 102.↵
- 103.
- 104.↵
- 105.
- 106.
- 107.↵
- 108.↵
- 109.
- 110.
- 111.↵
- 112.↵
- 113.↵
- 114.↵
- 115.
- 116.
- 117.
- 118.↵
- 119.↵
- 120.↵
- 121.↵
- 122.↵
- 123.↵
- 124.↵
- 125.↵
- 126.
- 127.
- 128.
- 129.↵
- 130.
- 131.↵
- 132.↵
- 133.↵
- 134.↵
- 135.
- 136.
- 137.↵
- 138.
- 139.
- 140.
- 141.↵
- 142.↵
- 143.↵
- 144.↵
- 145.
- 146.
- 147.
- 148.
- 149.↵
- 150.↵
- 151.
- 152.
- 153.
- 154.
- 155.
- 156.↵
- 157.↵
- 158.↵
- 159.↵
- 160.↵
- 161.↵
- 162.↵
- 163.↵
- 164.↵
- 165.↵
- 166.↵
- 167.↵
- 168.↵
- 169.↵
- 170.↵
- 171.↵
- 172.
- 173.
- 174.
- 175.
- 176.
- 177.
- 178.
- 179.
- 180.
- 181.
- 182.
- 183.
- 184.
- 185.
- 186.
- 187.
- 188.
- 189.
- 190.
- 191.
- 192.
- 193.
- 194.
- 195.
- 196.
- 197.
- 198.